Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-298682
Filing Date
2023-12-19
Accepted
2023-12-19 16:53:10
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d46116d424b5.htm 424B5 472510
2 GRAPHIC g46116g00x00.jpg GRAPHIC 67673
3 GRAPHIC g46116g02n32.jpg GRAPHIC 78757
4 GRAPHIC g46116g02n49.jpg GRAPHIC 75790
  Complete submission text file 0001193125-23-298682.txt   775966
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

EIN.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-271160 | Film No.: 231498130
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)